A randomized double-blind trial of TQB2450 with or without anlotinib in pretreated driver-negative non-small cell lung cancer
Wei Zhang, Jing Wang, Qiming Wang, Ying Cheng, Lei Yang, Yuechuan Li, Hua Zhong, Tianqing Chu, Yu Dong, Yanwei Zhang, Fangfei Qian, Liwen Xiong, Chunlei Shi, Cuicui Zhang, Zhen He, Jing Zhu, Xiting Liu, Hui Ma, K. Li, Baohui Han
Topics & Concepts
MedicineInternal medicinePlaceboLung cancerProgression-free survivalOncologyRandomized controlled trialGastroenterologyChemotherapySurgeryPathologyAlternative medicineLung Cancer Research StudiesCancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations